Universal Corporation — Form 10-Q Summary
Reporting period: Quarter and six months ended September 30, 2023, corresponding to fiscal Q2 and first half of fiscal 2024. The request metadata says “2022 Q2,” but the filing itself reports 2023 results.
Business context
Universal is a global business-to-business supplier of leaf tobacco and plant-based food and beverage ingredients. Results are seasonal, with substantial tobacco working-capital needs in the first half and shipments generally weighted toward the second half.
Financial results and liquidity
| Metric | Three months ended Sep. 30, 2023 | Six months ended Sep. 30, 2023 |
|---|---|---|
| Revenue | $638.5 million, down 1.9% | $1,156.2 million, up 7.0% |
| Operating income | $55.3 million, up 46% | $66.3 million, up 30% |
| Net income attributable to Universal | $28.1 million, versus $21.9 million | $26.1 million, versus $28.7 million |
| Diluted EPS | $1.12, versus $0.88 | $1.04, versus $1.15 |
| Adjusted diluted EPS, non-GAAP | $1.21, versus $0.88 | $1.13, versus $1.13 |
First-half gross margin increased to 18.9% from 17.6%, an improvement of 130 basis points. Interest expense rose $13.6 million to $32.6 million for the half, primarily because of higher interest rates. First-half operating cash flow was $10.5 million, compared with cash used of $346.2 million in the prior-year period; management attributed the improvement chiefly to tobacco sales mix and shipment and customer-payment timing. Capital expenditures were $32.6 million.
At September 30, 2023, cash was $99.7 million; notes payable and overdrafts were $301.4 million; and long-term debt was $617.1 million. Net debt as defined by the company was 42% of net capitalization, versus 44% a year earlier and 35% at March 31, 2023. Universal reported $445 million available under its committed revolving credit facility and about $150 million under uncommitted lines, and said it was in compliance with debt covenants. No long-term debt matures before fiscal 2028.
Material changes and management commentary
- Tobacco Operations: First-half segment revenue rose 9% to $998.6 million and operating income rose 46% to $61.3 million. Management cited strong demand, higher sales prices, and favorable product mix, despite lower volumes. Uncommitted tobacco inventory was 12% of total tobacco inventory at quarter-end; management expected low levels to continue.
- Ingredients Operations: First-half revenue declined 3% to $157.6 million and operating income fell 69% to $2.8 million, amid weak first-half demand and customers working through excess inventories. Second-quarter operating income increased modestly year over year as demand stabilized for some customers. Management said some raw-material prices, including apple prices, were declining.
- Reported first-half net income and EPS declined, while adjusted EPS was flat. The company reported $2.6 million of restructuring and impairment costs in the period; adjusted results exclude these costs and specified prior-year Tanzania-related items.
- Customer advances and deposits rose to $166.5 million from $12.6 million a year earlier, helping fund seasonal working capital. Tobacco inventory reached $1.1 billion, up $118.1 million year over year.
Outlook, risks, and contingencies
Management said tobacco shipments are expected to be strongly weighted to the second half of fiscal 2024. It expects to spend approximately $60 million to $70 million on capital projects over the next 12 months, including investments in the ingredients platform. The filing provides no earnings or revenue forecast.
Risks identified include seasonal crop and shipment variability, reliance on a small number of large tobacco customers, supply and demand changes, inflation and higher financing costs, foreign-exchange movements, weather and geopolitical conditions, regulation, and risks in the plant-based ingredients businesses. Management reported no material change to the risk factors in its latest annual report.
Brazilian subsidiaries continue to contest VAT assessments in Santa Catarina and Paraná. The remaining assessments were approximately $10 million and $3 million, respectively; management considered no loss probable and recorded no liability. Other contingent liabilities, primarily letters of credit, were about $1 million. The company said other litigation and tax matters were not expected to have a material adverse effect, while noting an adverse outcome could materially affect a particular period.
Other notable items: the company began restructuring its Global Labs Services facility and incurred $1.8 million in related costs, plus $0.8 million of termination costs elsewhere in Tobacco Operations. The board’s share-repurchase authorization had $95.3 million remaining at quarter-end. A 1% change in short-term rates was estimated to change annual interest expense by about $6.1 million before partial mitigation from customer charges.
Investor verification points
- Confirm the filing period: this is the quarter ended September 30, 2023, not 2022.
- Track second-half tobacco shipments, crop availability, product mix, and the level of uncommitted inventory.
- Monitor whether Ingredients Operations demand recovers and whether customer inventory and raw-material pricing trends improve.
- Assess seasonal cash conversion, inventory funding, customer advances, borrowing levels, and interest-rate exposure.
- Review the status and potential financial effect of the Brazilian VAT disputes and the $60 million to $70 million capital-spending plan.